Researchers at the Cleveland Clinic have identified a specific gut-produced compound that correlates with irregular heartbeats. The study suggests that consuming foods rich in choline and carnitine, such as beef and egg yolks, may increase the risk of atrial fibrillation.
The 70% increase in atrial fibrillation odds
The Cleveland Clinic recently published findings in the Journal of Clinical Investigation involving a study of 5,000 people in the United States. As the report notes, individuals with elevated levels of trimethylamine N-oxide (TMAO) in their blood faced 70% higher odds of developing atrial fibrillation compared to those with the lowest levels. this correlation persisted even when researchers accounted for established risk factors like obesity, high blood pressure, and advanced age.
How TMAO turns beef and egg yolks into heart risks
The biological mechanism involves the gut microbiome's reaction to specific nutrients found in common foods. according to the study, when people consume beef steak, liver, pork, or egg yolks, the gut produces TMAO from carnitine and choline. Robert Koeth, an electrophysiologist at the Cleveland Clinic, suggested that these findings might allow for much earlier dietary interventions to manage heart rhythm problems. This research reinforces the growing scientific consensus that heart health is inextricably linked to the health of the gut.
For those already suffering from the condition, symptoms can be debilitating, including extreme fatigue, chest pains, shortness of breath, or feeling faint. Because atrial fibrillation causes the heart to beat irregularly, it places immense strain on the cardiovascular system, potentially leading to heart failure.
Iodomethylcholine and the mouse-to-human gap
While the connection is clear in humans, researchers turned to animal models to test potential solutions. In experiments conducted by the Cleveland Clinic, mice fed diets high in choline developed atrial fibrillation more rapidly than those on standard diets. However, the study also identified a potential pharmaceutical path: an experimental drug called iodomethylcholine was able to delay the onset of the condition in mice by preventing gut bacteria from converting choline into TMAO.
Despite these promising results, several critical questions remain unanswered. It is currently unknown if iodomethylcholine can be safely administered to humans or if it will maintain its efficacy in a complex human microbiome. Furthermore, while the study highlights a link, it remains to be seen whether reducing choline intake is more effective than using targeted drugs to block TMAO production.. The researchers have not yet tested this drug on human subjects, leaving the clinical utility of the discovery in limbo.
A 50% spike in UK diagnoses and the stroke threat
The implications of this research are particularly urgent in the United Kingdom, where the British Heart Foundation (BHF) reports that atrial fibrillation diagnoses jumped by 50% between 2013 and 2023. The BHF notes that approximately 1.5 million people in the UK live with the condition, and an estimated 270,000 people may be living with it without even knowing .
The severity of the condition is further highlighted by a 2024 Danish study published in the British Medical Journal, which found that 40% of people with atrial fibrillation are likely to develop heart failure during their lifetime. The BHF also warns that those with the condition are five times more likely to suffer a stroke. With cardiovascular diseases claiming roughly 170,000 lives annually in the UK, the ability to intercept the TMAO pathway could represent a major shift in public health strategy.
Comments 0